{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:13:13Z","timestamp":1749701593031,"version":"3.41.0"},"reference-count":0,"publisher":"Frontline Medical Communications, Inc.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"DOI":"10.12788\/cutis.1229","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T17:14:38Z","timestamp":1749662078000},"source":"Crossref","is-referenced-by-count":0,"title":["Actinic Keratosis Treatment With Diclofenac Gel 1%"],"prefix":"10.12788","volume":"115","author":[{"given":"Hannah","family":"Riva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","container-title":["Cutis"],"original-title":[],"link":[{"URL":"https:\/\/cdn.mdedge.com\/files\/s3fs-public\/issues\/articles\/CT115005012_e.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T17:14:39Z","timestamp":1749662079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdedge.com\/cutis\/article\/272585\/nonmelanoma-skin-cancer\/actinic-keratosis-treatment-diclofenac-gel-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":0,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,1]]},"published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.12788\/cutis.1229","relation":{},"subject":[],"published":{"date-parts":[[2025,5,1]]}}}